Debra T. Auguste
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Debra T. Auguste has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Francisco R. Hung
Northeastern University
5 shared publications Peng Guo
Vascular Biology Program, Boston Children's Hospital, Boston, MA 02115
4 shared publicationsDanielle E. Large
Department of Bioengineering, Northeastern University, Boston, Massachusetts 02115, United States
3 shared publications- Daxing Liu
Department of Biomedical Engineering, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA
3 shared publications Jiaming Xu
Department of Chemical Engineering
3 shared publications- Marsha A. Moses
Vascular Biology Program Boston Children's Hospital Boston MA 02115 USA
3 shared publications
Latest Publications
- 7 July 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 385, 114019
The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer
- 7 July 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 385, 114019
The impact of peptide surface density on PD-L1 receptor inhibition as a therapeutic strategy for triple negative breast cancer
- Open Access
- 21 January 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (4) , 2600-2618
Effects of Lipid Headgroups on the Mechanical Properties and In Vitro Cellular Internalization of Liposomes
We performed all-atom and coarse-grained simulations of lipid bilayer mixtures of the unsaturated lipid DOPC, with saturated lipids having the same 18-carbon acyl tails and different headgroups, to understand their mechanical properties. The secondary lipids were DSPG, DSPA, DSPS, DSPC, and DSPE. The DOPC:DSPG system with 65:35 molar ratio was the softest, with area compressibility modulus KA ∼ 22% smaller than the pure DOPC value. Raising the mole % of DOPC leads to increases in KA, yet at any given composition the KA trend is DSPG < DSPA < DSPS < DSPC < DSPE. Lipid-lipid interactions are weaker in DOPC:DSPG mixtures and stronger in DSPE systems. The head and phosphate groups of the secondary lipids DSPG, DSPA, and DSPS interact strongly with salt ions. Adding secondary lipids leads to DOPC having more ordered acyl tails relative to pure DOPC systems. No evidence of phase separation or inhomogeneities was observed in our simulations. We synthesized three liposomal formulations, L-DOPC (pure DOPC) and L-DOPC/DSPG and L-DOPC/DSPA, both with 15 mol % of secondary lipid. L-DOPC/DSPA had approximately 3- and 2-times higher in vitro internalization by normal epithelial (EpH4-Ev) and metastatic breast cancer (4T1) cells, compared with L-DOPC. The uptake of L-DOPC/DSPG by EpH4-Ev cells was almost 2-fold compared to L-DOPC, but both liposomes had similar uptakes by cancer cells. As L-DOPC/DSPG and L-DOPC/DSPA have similar KA values, we presumed that the mechanical properties, possibly in combination with the higher negative surface charges in L-DOPC/DSPA and differences in effective liposome diameters and diffusivities, contributed to these observations.
- 21 January 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (4) , 2600-2618
Open AccessEffects of Lipid Headgroups on the Mechanical Properties and In Vitro Cellular Internalization of Liposomes
We performed all-atom and coarse-grained simulations of lipid bilayer mixtures of the unsaturated lipid DOPC, with saturated lipids having the same 18-carbon acyl tails and different headgroups, to understand their mechanical properties. The secondary lipids were DSPG, DSPA, DSPS, DSPC, and DSPE. The DOPC:DSPG system with 65:35 molar ratio was the softest, with area compressibility modulus KA ∼ 22% smaller than the pure DOPC value. Raising the mole % of DOPC leads to increases in KA, yet at any given composition the KA trend is DSPG < DSPA < DSPS < DSPC < DSPE. Lipid-lipid interactions are weaker in DOPC:DSPG mixtures and stronger in DSPE systems. The head and phosphate groups of the secondary lipids DSPG, DSPA, and DSPS interact strongly with salt ions. Adding secondary lipids leads to DOPC having more ordered acyl tails relative to pure DOPC systems. No evidence of phase separation or inhomogeneities was observed in our simulations. We synthesized three liposomal formulations, L-DOPC (pure DOPC) and L-DOPC/DSPG and L-DOPC/DSPA, both with 15 mol % of secondary lipid. L-DOPC/DSPA had approximately 3- and 2-times higher in vitro internalization by normal epithelial (EpH4-Ev) and metastatic breast cancer (4T1) cells, compared with L-DOPC. The uptake of L-DOPC/DSPG by EpH4-Ev cells was almost 2-fold compared to L-DOPC, but both liposomes had similar uptakes by cancer cells. As L-DOPC/DSPG and L-DOPC/DSPA have similar KA values, we presumed that the mechanical properties, possibly in combination with the higher negative surface charges in L-DOPC/DSPA and differences in effective liposome diameters and diffusivities, contributed to these observations.
- Open Access
- 31 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Effects of Lipid Headgroups on the Mechanical Properties and In Vitro Cellular Internalization of Liposomes
We performed all-atom and coarse-grained simulations of lipid bilayers mixtures of the unsaturated lipid DOPC, with saturated lipids having the same 18-carbon acyl tails and different headgroups, to understand their mechanical properties. The secondary lipids were DSPG, DSPA, DSPS, DSPC and DSPE. The DOPC:DSPG system with 65:35 molar ratio was the softest, with area compressibility modulus KA ~22% smaller than the pure DOPC value. Raising the mole% of DOPC leads to increases in KA, yet at any given composition the KA trend is DSPG <DSPA <DSPS <DSPC <DSPE. Lipid-lipid interactions are weaker in DOPC:DSPG mixtures and stronger in DSPE systems. The head and phosphate groups of the secondary lipids DSPG, DSPA and DSPS interact strongly with salt ions. Adding secondary lipids lead to DOPC having more ordered acyl tails relative to pure DOPC systems. No evidence of phase separation or inhomogeneities was observed in our simulations. We synthesized three liposomal formulations, L-DOPC (pure DOPC), and L-DOPC/DSPG and L-DOPC/DSPA, both with 15 mol% of secondary lipid. L-DOPC/DSPA had approximately 3- and 2-times higher in vitro internalization by normal epithelial (EpH4-Ev) and metastatic breast cancer (4T1) cells, compared with L-DOPC. The uptake of L-DOPC/DSPG by EpH4-Ev cells was almost 2-fold compared to L-DOPC, but both liposomes had similar uptakes by cancer cells. As L-DOPC/DSPG and L-DOPC/DSPA have similar KA values, we presumed that the mechanical properties, possibly in combination with higher negative surface charges in L-DOPC/DSPA and differences in effective liposome diameters and diffusivities, contributed to these observations.
- 31 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEffects of Lipid Headgroups on the Mechanical Properties and In Vitro Cellular Internalization of Liposomes
We performed all-atom and coarse-grained simulations of lipid bilayers mixtures of the unsaturated lipid DOPC, with saturated lipids having the same 18-carbon acyl tails and different headgroups, to understand their mechanical properties. The secondary lipids were DSPG, DSPA, DSPS, DSPC and DSPE. The DOPC:DSPG system with 65:35 molar ratio was the softest, with area compressibility modulus KA ~22% smaller than the pure DOPC value. Raising the mole% of DOPC leads to increases in KA, yet at any given composition the KA trend is DSPG <DSPA <DSPS <DSPC <DSPE. Lipid-lipid interactions are weaker in DOPC:DSPG mixtures and stronger in DSPE systems. The head and phosphate groups of the secondary lipids DSPG, DSPA and DSPS interact strongly with salt ions. Adding secondary lipids lead to DOPC having more ordered acyl tails relative to pure DOPC systems. No evidence of phase separation or inhomogeneities was observed in our simulations. We synthesized three liposomal formulations, L-DOPC (pure DOPC), and L-DOPC/DSPG and L-DOPC/DSPA, both with 15 mol% of secondary lipid. L-DOPC/DSPA had approximately 3- and 2-times higher in vitro internalization by normal epithelial (EpH4-Ev) and metastatic breast cancer (4T1) cells, compared with L-DOPC. The uptake of L-DOPC/DSPG by EpH4-Ev cells was almost 2-fold compared to L-DOPC, but both liposomes had similar uptakes by cancer cells. As L-DOPC/DSPG and L-DOPC/DSPA have similar KA values, we presumed that the mechanical properties, possibly in combination with higher negative surface charges in L-DOPC/DSPA and differences in effective liposome diameters and diffusivities, contributed to these observations.
- Open Access
- 25 October 2023
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 127 (44) , 9496-9512
Understanding the Mechanical Properties of Ultradeformable Liposomes Using Molecular Dynamics Simulations
Improving drug delivery efficiency to solid tumor sites is a central challenge in anticancer therapeutic research. Our previous experimental study (Guo et al., Nat. Commun. 2018, 9, 130) showed that soft, elastic liposomes had increased uptake and accumulation in cancer cells and tumors in vitro and in vivo respectively, relative to rigid particles. As a first step toward understanding how liposomes' molecular structure and composition modulates their elasticity, we performed all-atom and coarse-grained classical molecular dynamics (MD) simulations of lipid bilayers formed by mixing a long-tailed unsaturated phospholipid with a short-tailed saturated lipid with the same headgroup. The former types of phospholipids considered were 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (termed here DPMPC). The shorter saturated lipids examined were 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). Several lipid concentrations and surface tensions were considered. Our results show that DOPC or DPMPC systems having 25-35 mol % of the shortest lipids DHPC or DDPC are the least rigid, having area compressibility moduli KA that are ∼10% smaller than the values observed in pure DOPC or DPMPC bilayers. These results agree with experimental measurements of the stretching modulus and lysis tension in liposomes with the same compositions. These mixed systems also have lower areas per lipid and form more uneven x-y interfaces with water, the tails of both primary and secondary lipids are more disordered, and the terminal methyl groups in the tails of the long lipid DOPC or DPMPC wriggle more in the vertical direction, compared to pure DOPC or DPMPC bilayers or their mixtures with the longer saturated lipid DLPC or DMPC. These observations confirm our hypothesis that adding increasing concentrations of the short unsaturated lipid DHPC or DDPC to DOPC or DPMPC bilayers alters lipid packing and thus makes the resulting liposomes more elastic and less rigid. No formation of lipid nanodomains was noted in our simulations, and no clear trends were observed in the lateral diffusivities of the lipids as the concentration, type of secondary lipid, and surface tension were varied.
- 25 October 2023
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 127 (44) , 9496-9512
Open AccessUnderstanding the Mechanical Properties of Ultradeformable Liposomes Using Molecular Dynamics Simulations
Improving drug delivery efficiency to solid tumor sites is a central challenge in anticancer therapeutic research. Our previous experimental study (Guo et al., Nat. Commun. 2018, 9, 130) showed that soft, elastic liposomes had increased uptake and accumulation in cancer cells and tumors in vitro and in vivo respectively, relative to rigid particles. As a first step toward understanding how liposomes' molecular structure and composition modulates their elasticity, we performed all-atom and coarse-grained classical molecular dynamics (MD) simulations of lipid bilayers formed by mixing a long-tailed unsaturated phospholipid with a short-tailed saturated lipid with the same headgroup. The former types of phospholipids considered were 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (termed here DPMPC). The shorter saturated lipids examined were 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). Several lipid concentrations and surface tensions were considered. Our results show that DOPC or DPMPC systems having 25-35 mol % of the shortest lipids DHPC or DDPC are the least rigid, having area compressibility moduli KA that are ∼10% smaller than the values observed in pure DOPC or DPMPC bilayers. These results agree with experimental measurements of the stretching modulus and lysis tension in liposomes with the same compositions. These mixed systems also have lower areas per lipid and form more uneven x-y interfaces with water, the tails of both primary and secondary lipids are more disordered, and the terminal methyl groups in the tails of the long lipid DOPC or DPMPC wriggle more in the vertical direction, compared to pure DOPC or DPMPC bilayers or their mixtures with the longer saturated lipid DLPC or DMPC. These observations confirm our hypothesis that adding increasing concentrations of the short unsaturated lipid DHPC or DDPC to DOPC or DPMPC bilayers alters lipid packing and thus makes the resulting liposomes more elastic and less rigid. No formation of lipid nanodomains was noted in our simulations, and no clear trends were observed in the lateral diffusivities of the lipids as the concentration, type of secondary lipid, and surface tension were varied.
- Open Access
- 16 October 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (11) , 5500-5514
Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer
Lysophosphatidic acid receptor 1 (LPAR1) is elevated in breast cancer. The deregulation of LPAR1, including the function and level of expression, is linked to cancer initiation, progression, and metastasis. LPAR1 antagonists, AM095 or Ki16425, may be effective therapeutic molecules, yet their limited water solubility hinders in vivo delivery. In this study, we report on the synthesis of two liposomal formulations incorporating AM095 or Ki16425, embedded within the lipid bilayer, as targeted nanocarriers for metastatic breast cancer (MBC). The data show that the Ki16425 liposomal formulation exhibited a 50% increase in internalization by MBC mouse epithelial cells (4T1) and a 100% increase in tumor accumulation in a mouse model of MBC compared with that of a blank liposomal formulation (control). At the same time, normal mouse epithelial cells (EpH-4Ev) internalized the Ki16425 liposomal formulation 25% lesser than the control formulation. Molecular dynamics simulations show that the integration of AM095 or Ki16425 modified the physical and mechanical properties of the lipid bilayer, making it more flexible in these liposomal formulations compared with liposomes without drug. The incorporation of an LPAR1 antagonist within a liposomal drug delivery system represents a viable therapeutic approach for targeting the LPA-LPAR1 axis, which may hinder the progression of MBC.
- 16 October 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (11) , 5500-5514
Open AccessIntegration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer
Lysophosphatidic acid receptor 1 (LPAR1) is elevated in breast cancer. The deregulation of LPAR1, including the function and level of expression, is linked to cancer initiation, progression, and metastasis. LPAR1 antagonists, AM095 or Ki16425, may be effective therapeutic molecules, yet their limited water solubility hinders in vivo delivery. In this study, we report on the synthesis of two liposomal formulations incorporating AM095 or Ki16425, embedded within the lipid bilayer, as targeted nanocarriers for metastatic breast cancer (MBC). The data show that the Ki16425 liposomal formulation exhibited a 50% increase in internalization by MBC mouse epithelial cells (4T1) and a 100% increase in tumor accumulation in a mouse model of MBC compared with that of a blank liposomal formulation (control). At the same time, normal mouse epithelial cells (EpH-4Ev) internalized the Ki16425 liposomal formulation 25% lesser than the control formulation. Molecular dynamics simulations show that the integration of AM095 or Ki16425 modified the physical and mechanical properties of the lipid bilayer, making it more flexible in these liposomal formulations compared with liposomes without drug. The incorporation of an LPAR1 antagonist within a liposomal drug delivery system represents a viable therapeutic approach for targeting the LPA-LPAR1 axis, which may hinder the progression of MBC.
- Open Access
- 20 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Understanding the Mechanical Properties of Ultra-Deformable Liposomes Using Molecular Dynamics Simulations
Improving drug delivery efficiency to solid tumor sites is a central challenge in anti-cancer therapeutic research. Our previous experimental study (Guo et al., Nat. Commun. 2018, 9, 130) showed that soft, elastic liposomes had increased uptake and accumulation in cancer cells and tumors in vitro and in vivo respectively, relative to rigid particles. As a first step towards understanding how liposomes’ molecular structure and composition modulates their elasticity, we performed all-atom and coarse-grained classical molecular dynamics (MD) simulations of lipid bilayers formed by mixing a long-tailed, unsaturated phospholipid with a short-tailed saturated lipid with the same head group. The former type of phospholipids considered were 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (termed here DPMPC). The shorter saturated lipids examined were 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). Several lipid concentrations and surface tensions were considered. Our results show that DOPC or DPMPC systems having 25-35 mol% of the shortest lipids DHPC or DDPC are the least rigid, having area compressibility moduli KA that are ~10% smaller than the values observed in pure DOPC or DPMPC bilayers. These results agree with experimental measurements of the stretching modulus and lysis tension in liposomes with the same compositions. These systems also have lower areas per lipid, form more uneven x-y interfaces with water, the tails of both primary and secondary lipids are more disordered, and the terminal methyl groups in the tails of the long lipids DOPC or DPMPC wriggle more in the vertical direction, compared to pure DOPC or DPMPC bilayers or their mixtures with the longer saturated lipids DLPC or DMPC. These observations confirm our hypothesis that adding increasing concentrations of the short unsaturated lipids DHPC or DDPC to DOPC or DPMPC bilayers, alters lipid packing and thus make the resulting liposomes more elastic and less rigid. No formation of lipid nanodomains was noted in our simulations, and no clear trends were observed in the lateral diffusivities of the lipids as concentration, type of secondary lipid and surface tension were varied.
- 20 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessUnderstanding the Mechanical Properties of Ultra-Deformable Liposomes Using Molecular Dynamics Simulations
Improving drug delivery efficiency to solid tumor sites is a central challenge in anti-cancer therapeutic research. Our previous experimental study (Guo et al., Nat. Commun. 2018, 9, 130) showed that soft, elastic liposomes had increased uptake and accumulation in cancer cells and tumors in vitro and in vivo respectively, relative to rigid particles. As a first step towards understanding how liposomes’ molecular structure and composition modulates their elasticity, we performed all-atom and coarse-grained classical molecular dynamics (MD) simulations of lipid bilayers formed by mixing a long-tailed, unsaturated phospholipid with a short-tailed saturated lipid with the same head group. The former type of phospholipids considered were 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dipalmitoleoyl-sn-glycero-3-phosphocholine (termed here DPMPC). The shorter saturated lipids examined were 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC), 1,2-didecanoyl-sn-glycero-3-phosphocholine (DDPC), 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). Several lipid concentrations and surface tensions were considered. Our results show that DOPC or DPMPC systems having 25-35 mol% of the shortest lipids DHPC or DDPC are the least rigid, having area compressibility moduli KA that are ~10% smaller than the values observed in pure DOPC or DPMPC bilayers. These results agree with experimental measurements of the stretching modulus and lysis tension in liposomes with the same compositions. These systems also have lower areas per lipid, form more uneven x-y interfaces with water, the tails of both primary and secondary lipids are more disordered, and the terminal methyl groups in the tails of the long lipids DOPC or DPMPC wriggle more in the vertical direction, compared to pure DOPC or DPMPC bilayers or their mixtures with the longer saturated lipids DLPC or DMPC. These observations confirm our hypothesis that adding increasing concentrations of the short unsaturated lipids DHPC or DDPC to DOPC or DPMPC bilayers, alters lipid packing and thus make the resulting liposomes more elastic and less rigid. No formation of lipid nanodomains was noted in our simulations, and no clear trends were observed in the lateral diffusivities of the lipids as concentration, type of secondary lipid and surface tension were varied.
- 16 November 2022
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (11) , 1955-1956
What Comes after Liposomes?
- 16 November 2022
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 33 (11) , 1955-1956
What Comes after Liposomes?
- Top Cited Papers
- 1 September 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 176, 113851
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
- 1 September 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 176, 113851
Top Cited PapersLiposome composition in drug delivery design, synthesis, characterization, and clinical application
- 12 January 2021
- Published by Wiley in Advanced Therapeutics
- Vol. 4 (3)
A Lipid Targeting, pH‐Responsive Nanoemulsion Encapsulating a DNA Intercalating Agent and HDAC Inhibitor Reduces TNBC Tumor Burden
Triple negative breast cancers (TNBCs) represent a heterogenous disease with high patient mortality relative to other breast cancers. Doxorubicin (Dox), a DNA intercalating drug, is widely used as chemotherapy for TNBC. However, it often accompanies severe side effects that limit the effective therapeutic dose. It is hypothesized that the combination of Dox with a histone deacetylase inhibitor, panobinostat (Pan), may improve therapeutic efficacy by attacking rapid cell proliferation and abnormal histone deacetylation. Herein, pH‐responsive, lipid targeting nanoemulsions (pLNEs) are designed to direct both Dox and Pan to TNBC cells that overexpress lysophosphatidic acid (LPA) receptor 1 (LPAR 1 ) via the ratio of LPA to lysophosphatidylcholine and trigger Dox release via disassociation from docosahexanoic acid. Dox/Pan‐pLNEs result in higher intranuclear Dox compared to free Dox, free Dox/Pan, and Dox‐pLNEs. Tumors treated with Dox/Pan‐pLNEs exhibit 2.4‐fold reduction in tumor burden relative to free Dox alone. Molecular analysis reveals that MDA‐MB‐231 tumor growth inhibition is mediated by re‐expression of thioredoxin‐interacting protein and suppression of cytoplasmic p27 kip1 and c‐Jun activation domain‐binding protein‐1. This lipid targeting, Dox/Pan encapsulating pLNE represents a platform for treating TNBC with greater therapeutic efficacy.
- 12 January 2021
- Published by Wiley in Advanced Therapeutics
- Vol. 4 (3)
A Lipid Targeting, pH‐Responsive Nanoemulsion Encapsulating a DNA Intercalating Agent and HDAC Inhibitor Reduces TNBC Tumor Burden
Triple negative breast cancers (TNBCs) represent a heterogenous disease with high patient mortality relative to other breast cancers. Doxorubicin (Dox), a DNA intercalating drug, is widely used as chemotherapy for TNBC. However, it often accompanies severe side effects that limit the effective therapeutic dose. It is hypothesized that the combination of Dox with a histone deacetylase inhibitor, panobinostat (Pan), may improve therapeutic efficacy by attacking rapid cell proliferation and abnormal histone deacetylation. Herein, pH‐responsive, lipid targeting nanoemulsions (pLNEs) are designed to direct both Dox and Pan to TNBC cells that overexpress lysophosphatidic acid (LPA) receptor 1 (LPAR 1 ) via the ratio of LPA to lysophosphatidylcholine and trigger Dox release via disassociation from docosahexanoic acid. Dox/Pan‐pLNEs result in higher intranuclear Dox compared to free Dox, free Dox/Pan, and Dox‐pLNEs. Tumors treated with Dox/Pan‐pLNEs exhibit 2.4‐fold reduction in tumor burden relative to free Dox alone. Molecular analysis reveals that MDA‐MB‐231 tumor growth inhibition is mediated by re‐expression of thioredoxin‐interacting protein and suppression of cytoplasmic p27 kip1 and c‐Jun activation domain‐binding protein‐1. This lipid targeting, Dox/Pan encapsulating pLNE represents a platform for treating TNBC with greater therapeutic efficacy.
- Open Access
- 11 May 2020
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 48 (7) , 1863
ABME Special Issue Editorial: Engineering Cell Behavior
- 11 May 2020
- Published by Springer Nature in Annals of Biomedical Engineering
- Vol. 48 (7) , 1863
Open AccessABME Special Issue Editorial: Engineering Cell Behavior